MindWalk Holdings (HYFT) Convertible Debt (2020)
MindWalk Holdings (HYFT) reported Convertible Debt of $1.6 million for Q4 2020, up 585.4% quarter-over-quarter from $227995.8 in Q2 2020.
MindWalk Holdings (HYFT) Convertible Debt (2020) Analysis & Trends
MindWalk Holdings (HYFT) has 1 years of Convertible Debt data on file, last reported at $1.6 million in Q4 2020.
- Convertible Debt for Q4 2020 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Oct 2020 was $1.6 million (changed N/A YoY), and the FY2020 annual result was $227995.8, changed N/A from the prior year.
- Convertible Debt climbed to $1.6 million in Q4 2020 per HYFT's latest filing, from $227995.8 in the prior quarter.
- Over five years, Convertible Debt peaked at $1.6 million in Q4 2020 and troughed at $227995.8 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2020 | 1.56 Mn |
| Apr 30, 2020 | 227,995.83 |